Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • CJASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • JASN Podcasts
    • Article Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
  • Editorial Fellowship
    • Editorial Fellowship Team
    • Editorial Fellowship Application Process
  • More
    • About JASN
    • Advertising
    • Alerts
    • Feedback
    • Impact Factor
    • Reprints
    • Subscriptions
  • ASN Kidney News
  • Follow JASN on Twitter
  • Visit ASN on Facebook
  • Follow JASN on RSS
  • Community Forum
Cell and Transport Physiology
You have accessRestricted Access

Role of Organic Anion Transporters in the Tubular Transport of Indoxyl Sulfate and the Induction of its Nephrotoxicity

Atsushi Enomoto, Michio Takeda, Akihiro Tojo, Takashi Sekine, Seok Ho Cha, Suparat Khamdang, Fumio Takayama, Isao Aoyama, Sakurako Nakamura, Hitoshi Endou and Toshimitsu Niwa
JASN July 2002, 13 (7) 1711-1720; DOI: https://doi.org/10.1097/01.ASN.0000022017.96399.B2
Atsushi Enomoto
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michio Takeda
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akihiro Tojo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Sekine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seok Ho Cha
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suparat Khamdang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fumio Takayama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isao Aoyama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sakurako Nakamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hitoshi Endou
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshimitsu Niwa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

ABSTRACT. In uremic patients, various uremic toxins are accumulated and exert various biologic effects on uremia. Indoxyl sulfate (IS) is one of uremic toxins that is derived from dietary protein, and serum levels of IS are markedly increased in both uremic rats and patients. It has been previously reported that the accumulation of IS promotes the progression of chronic renal failure (CRF). This study demonstrates the role of rat organic anion transporters (rOATs) in the transport of IS and the induction of its nephrotoxicity. The administration of IS to 5/6-nephrectomized rats caused a faster progression of CRF, and immunohistochemistry revealed that IS was detected in the proximal and distal tubules where rOAT1 (proximal tubules) and/or rOAT3 (proximal and distal tubules) were also shown to be localized. In in vitro study, the proximal tubular cells derived from mouse that stably express rOAT1 (S2 rOAT1) and rOAT3 (S2 rOAT3) were established. IS inhibited organic anion uptake by S2 rOAT1 and S2 rOAT3, and the Ki values were 34.2 and 74.4 μM, respectively. Compared with mock, S2 rOAT1 and S2 rOAT3 exhibited higher levels of IS uptake, which was inhibited by probenecid and cilastatin, organic anion transport inhibitors. The addition of IS induced a decrease in the viability of S2 rOAT1 and S2 rOAT3 as compared with the mock, which was rescued by probenecid. These results suggest that rOAT1 and rOAT3 play an important role in the transcellular transport of IS and the induction of its nephrotoxicity.

There have been many reports that protein restriction delays the progression of chronic renal failure (CRF) in both experimental uremic rats (1,2) and undialyzed uremic patients (3,4). To date, various possible mediators of the effect of dietary protein on the progression of renal insufficiency have been indicated, including angiotensin II (5,6), transforming growth factor-β (7), eicosanoids (8), and glucocorticoids (9,10).

In addition to these compounds, biologically active circulating uremic toxins derived from dietary protein have been proposed to play an important role in the progression of renal damage ((11–13). We previously identified indoxyl sulfate (IS) as a uremic toxin derived from dietary protein. IS is metabolized by the liver from indole, which is produced from tryptophan by intestinal flora including Escherichia coli. We previously found that there is a marked elevation in the serum levels of IS in 5/6-nephrectomized (5/6-NPX) uremic rats and in uremic patients (11,12). In addition, a low-protein diet was shown to reduce the serum levels of IS in uremic rats (12,14). Furthermore, administration of AST-120, an oral absorbent, decreased the intensity of IS staining in the proximal tubules as well as the serum and urinary concentrations of IS; it also improved the slope of the time-dependent 1/serum creatinine plot (11,15). We have thus proposed a protein metabolite theory such that the increased serum concentration of uremic toxins, including IS and subsequent accumulation of those within the renal tubules in CRF possess the potential to exacerbate the deterioration of renal function (11,12). However, the mechanism by which IS is accumulated in the renal tubular cells and that of its nephrotoxicity remain unknown.

In the kidney, carrier-mediated secretory pathways for organic anions exist in the tubular cells (16,17). Various anionic drugs and substances are taken up into the tubular cells by basolateral multispecific organic anion transporters (OATs) and subsequently effluxed into the tubular lumen by luminal OATs. During transepithelial transport, organic anions are transiently accumulated in the proximal tubular cells. Over the past few years, we and others have identified various OATs, including OAT1 (18,19), OAT2 (20), OAT3 (21,22), and OAT4 (23). In addition, OAT homologues might also contribute to apical efflux of organic anions like PAH in vivo, i.e., organic anion-transporting polypeptide (oatp1) (24), OAT-K1 (25), OAT-K2 (26), multidrug resistance-associated protein 2 (MRP2) (27,28), and human-type I sodium-dependent inorganic phosphate transporter (NPT1) (29). Among them, rat OAT1 (rOAT1) and rat OAT3 (rOAT3) are the major OATs that are localized in the basolateral membrane of the proximal and distal tubules (30–32).

On the basis of its physicochemical properties, i.e., IS possesses an anionic moiety (Figure 1), we hypothesized that IS is a substrate for OATs and that the specific OAT involved may be related to the progression of CRF. We investigated the localization of accumulated IS and sites of rOAT1 and rOAT3 expression in 5/6-NPX rats after administration of IS using immunohistochemistry. We also elucidated the role of rOAT1 and rOAT3 in the transport of IS and the induction of its nephrotoxicity by using cells stably expressing rOAT1 and rOAT3.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Chemical structure of indoxyl sulfate (IS). Molecular weight, 213.23.

Materials and Methods

In Vivo Experimental Design

Male Sprague-Dawley rats (Clea, Tokyo, Japan) aged 7 wk were anesthetized, and five sixths of the normal kidney mass was infarcted, which induced CRF in most of the rats (33,34). Two days after the operation, the treated rats showed increased serum concentrations of creatinine (1.0 approximately 1.4 mg/dl), blood urea nitrogen (BUN) (67 approximately 92 mg/dl), and reduced levels of creatinine clearance (0.67 approximately 1.12 ml/min). Sham-operated rats as well as operated ones were given an intraperitoneal infusion of antibiotics (50 to 100 μl of 5000 U/ml penicillin-streptomycin; Life Technologies BRL, New York, NY).

Fourteen rats were paired and assigned to two separate groups: (1) 5/6-NPX rats (n = 7) and (2) 5/6-NPX rats orally administered IS in water daily at a dose of 50 mg/kg body wt and additionally receiving a daily intraperitoneal injection at a dose of 50 mg/kg body wt (n = 7). The administration of IS began at the fifth week after the nephrectomy and continued for 16 wk. At 0, 4, 10, and 16 wk after the initial administration of IS, BP measurement, the serum concentrations of creatinine, IS ,and BUN, the urinary concentrations of protein and IS, and the creatinine clearance levels were determined. BP was measured using the tails of the rats with a pneumatic cuff and a sphygmomanometer for small animals (UR-5000, Ueda Avancer Co., Tokyo, Japan). At the end of the experiments, the rats were sacrificed and the remnant kidneys were removed for immunohistochemical study.

Antibodies

The characterization of the monoclonal anti-IS antibody was described previously (15). There was no positive staining in the renal cortex when the primary antibody was preincubated with IS (data not shown) or when the primary antibody was omitted from the protocol. A rabbit polyclonal antibody was raised against a synthesized polypeptide of the carboxyl terminal of rOAT1 and rOAT3. The specificity of the antibody was described elsewhere (30,32).

Immunohistochemical Studies in 5/6-NPX Rat Kidney

Immunostaining of IS in renal tissue sections (1-μm-thick) was performed by the SABC (streptavidin-biotinylated peroxidase complex) method, as described previously (15,30). For immunohistochemical detection of rOAT1 and rOAT3, the sections were incubated with polyclonal antibodies against rOAT1 (1:2000 dilution) and rOAT3 (1:250 dilution), respectively. The sections were incubated with horseradish peroxidase (HRP)-conjugated secondary antibody against rabbit Ig (Dako, Glostrup, Denmark), and the HRP was detected using a diaminobenzidine (DAB)-H2O2 solution.

Cell Culture and Establishment of S2 Cells Stably Expressing rOAT1 and rOAT3 (S2 rOAT1 and S2 rOAT3)

An immortalized cell line derived from the second segment of the proximal tubule (S2) cells was established from the kidney of transgenic mice harboring the simian virus 40 large T-antigen gene as described previously (35,36). S2 cells do not express mouse OATs by RT-PCR (data not shown) and show a faint uptake of para-amino hippuric acid (PAH). Moreover, although protein kinase C activation downregulates estrone sulfate (ES) uptake by S2 rOAT3, other cells derived from the same transgenic mice did not show such regulation (37). Therefore, we assumed this cell line to be appropriate for the transfection. The establishment of S2 rOAT1 and S2 rOAT3 was carried out as described previously (36,37). Briefly, the full-length cDNAs of rOAT1 (18) and rOAT3 (21) were subcloned into pcDNA 3.1(+) (Invitrogen, San Diego, CA). S2 cells were transfected with pcDNA3.1-rOAT1 and pcDNA3.1-rOAT3 coupled with pSV2neo, a neomycin resistance gene, using TfX-50 according to the manufacturer’s instructions. S2 cells transfected with pcDNA3.1 lacking an insert and pSV2neo were designated S2 pcDNA 3.1 and used as a control. The cells were grown in a humidified incubator at 33°C under 5% CO2 using RITC 80–7 medium (Iwaki Co., Tokyo, Japan) containing 5% fetal bovine serum, 10 μg/ml transferrin, 0.08 U/ml insulin, 10 ng/ml recombinant epidermal growth factor and 400 μg/ml geneticin. The cells were subcultured in a medium containing 0.05% trypsin-EDTA solution (containing 137 mM NaCl, 5.4 mM KCl, 5.5 mM glucose, 4 mM NaHCO3, 0.5 mM EDTA, and 5 mM HEPES; pH 7.2). Clonal cells were isolated by using a cloning cylinder and screened by determining the optimal substrate for each transporter, i.e., [14C]PAH (53.1 mCi/mmol; Perkin Elmer Life Sciences, Boston, MA) (18) and [3H]ES (53 Ci/mmol; Perkin Elmer Life Sciences) for rOAT3 (21). Staining of vertical sections of S2 rOAT1 and S2 rOAT3 with polyclonal antibodies against rOAT1 and rOAT3, respectively, showed that the subcellular localization of rOAT1 and rOAT3 proteins was mainly on the cell membrane (36,38). Both the basolateral and apical portions of the membrane showed positive staining. Therefore, the cells were cultured on a solid support for subsequent experiments.

Uptake Experiments in S2 rOAT1 and S2rOAT3

Uptake experiments were performed as described previously (36–38). The cells were seeded in 24-well tissue culture plates at a cell density of 1 × 105 cells/well. After culturing for 2 d, they were washed three times with Dulbecco modified phosphate-buffered saline (D-PBS) solution (containing 137 mM NaCl, 3 mM KCl, 8 mM Na2HPO4, 1 mM KH2PO4, 1 mM CaCl2, and 0.5 mM MgCl2; pH 7.4). They were then preincubated in the same solution at 37°C for 10 min. The cells were thereafter incubated in D-PBS containing 5 μM [14C]PAH or 50 nM [3H]ES in the absence or presence of IS at 37°C. After incubation, the cells were washed three times with ice-cold D-PBS. The cells in each well were lysed with 0.5 ml of 0.1 M sodium hydroxide, 2.5 ml of aquasol-2 was added, and radioactivity was determined by using a β-scintillation counter (LSC-3100, Aloka, Co., Tokyo, Japan).

Kinetic Analyses

After preincubation as described above, S2 rOAT1 and S2 rOAT3 were incubated in a solution containing [14C]PAH or [3H]ES at different concentrations in the absence or presence of IS (Sigma, St. Louis, MO) at 37°C for 2 min. On the basis of the level of organic anion uptake under each condition, analyses of Lineweaver-Burk plot as well as Eadie-Hofstee plot were performed as described previously (39). When the inhibition was competitive, Ki values were calculated based on the following equation,

Ki = concentration of IS/[(Km PAH or ES with IS/Km PAH or ES without IS) − 1]

Measurement of Intracellular IS Content

S2 cells were seeded in 6-well tissue culture plates at a cell density of 3 × 105 cells/well, cultured, and preincubated as in the uptake experiments. The cells were thereafter incubated in a solution containing 100 μM IS in the absence or presence of 1 mM probenecid or 1 mM cilastatin at 37°C for 5, 15, and 30 min. After washing the cells with IS-free PBS, the intracellular concentrations of IS were determined using HPLC (40).

Cytotoxicity Assays

Cell viability was assessed using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) assay as described previously (38). S2 cells were incubated in a solution in the absence or presence of IS at 33°C for 24 or 48 h. In addition, to elucidate the protective effect of probenecid on IS-induced cytotoxicity, the cells were incubated in a solution containing IS in the absence or presence of 1 mM probenecid. After the incubation, 1 ml of 0.5% MTT was added to the media. The cells were then further incubated at 33°C for 4 h. After the cells were lysed with isopropanol/HCl solution, the optical density was measured at 570 nm using that at 630 nm as a reference (Beckman, Du-640).

Statistical Analyses

Results are expressed as the means ± SEM. To compare values among the three groups, ANOVA and Fisher’s least significance difference (LSD) test were performed. Results were considered statistically significant when the P value was less than 0.05.

Results

Biochemical Parameters in Vivo

As shown in Table 1, significant increases in systolic BP, serum creatinine, BUN, serum IS, and urinary protein excretion and significant decrease in creatinine clearance level were observed in 5/6-NPX rats compared with sham rats. In addition, 5/6-NPX rats administered with IS showed further increases in serum creatinine, BUN, serum IS, urinary IS excretion, and urinary protein excretion, with a decrease in creatinine clearance being much more predominant than in 5/6-NPX rats. Renal function deteriorated time-dependently until the 16th wk; remnant kidneys from 5/6-NPX rats with or without administration of IS were therefore used for immunohistologic analyses at week 16.

View this table:
  • View inline
  • View popup
Table 1.

Whole animal dataa

Localization of OAT1, OAT3, and IS in Renal Cortex by Immunohistochemistry

Immunohistochemical analyses were performed to determine the localization of rOAT1, rOAT3, and IS in various sections of the renal cortex. In the control, rOAT1 is localized in the basolateral membrane of the S2 segment of the proximal tubule but not in the S1 segment (Figure 2A), whereas rOAT3 is localized in the basolateral membrane of both S1 and S2 segments, the thick ascending limb of Henle (TAL), and the distal convoluted tubule (DCT) (Figure 2D) as well as the S3 segment (data not shown). The 5/6-NPX rats administered with IS showed increased intensity of staining for rOAT3 in the renal cortex as compared with control, and rOAT1 was found to be slightly induced in the S1 segment. IS was weakly stained in the proximal tubule but not in the glomeruli of control rats. In 5/6-NPX rats, IS was strongly localized in the S2 segments of proximal tubule and glomerular epithelial cells and weakly localized in the S1 segment, TAL, and DCT. The 5/6-NPX rats administered with IS showed a marked increase in IS immunoreactivity not only in the S1 and S2 segments of the proximal tubule but also in the glomerular epithelial cells, DCT, and TAL with macula densa. These data confirm the localization of IS and demonstrate that IS administration markedly enhances the tubular uptake of IS in the remnant kidney. In DCT and TAL with macula densa, IS staining was found to be colocalized with the staining of rOAT3 but not of rOAT1.

Figure2
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 2. Immunostaining of rOAT1, rOAT3, and IS in the renal cortex of control rats (Sham; A, D, and G), uremic rats (5/6-NPX; B, E, and H), and uremic rats to which IS was administered (5/6-NPX+IS; C, F, and I). Serial sections from each rat kidney were stained using a polyclonal anti-rOAT1 antibody (A, B, C), a polyclonal anti-rOAT3 antibody (D, E, F), and a monoclonal anti-IS antibody (G, H, I). These figures are representatives of typical samples from seven rats. The S1 segment of the proximal tubule (stars) was connected to the glomerulus, followed by the S2 segment. The thick ascending limb of the loop of Henle (TAL) is represented by triangles, the distal convoluted tubule (DCT) by circles, and the macula densa by arrows. Magnification x 150.

Effects of Various Concentrations of IS on rOAT1- and rOAT3-Mediated Organic Anion Uptake

As shown in Figure 3, S2 rOAT1 (A) and S2 rOAT3 (B) exhibited a time-dependent uptake of PAH and ES, respectively. In addition, S2 rOAT1 and S2 rOAT3 exhibited a dose-dependent increase in PAH and ES uptake, respectively (data not shown). Eadie-Hofstee analyses showed that the Michaelis constant (Km) for PAH uptake was 17.6 ± 5.6 μM in S2 rOAT1; for ES uptake, it was 4.30 ± 1.20 μM in S2 rOAT3, values which are similar to those in the Xenopus laevis oocyte expression system (18,21). As shown in Figure 3, IS inhibited the rOAT1-mediated (C) and rOAT3-mediated (D) organic anion uptake in a dose-dependent manner (n = 4; *P < 0.01 versus control). In contrast, IS did not significantly inhibit PAH uptake and/or ES uptake in S2 pcDNA 3.1 (n = 4; NS). As shown in Figure 4, kinetic analyses of the inhibitory effects were performed using Lineweaver-Burk plot (A and C) as well as Eadie-Hosfstee plot (B and D). The results of these kinetic analyses revealed that the mode of inhibition was competitive. The inhibition constant (Ki) values for rOAT1 and rOAT3 were determined to be 34.2 μM (n = 4) and 74.4 μM (n = 4), respectively.

Figure3
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 3. Effects of various concentrations of IS on rOAT1- and rOAT3-mediated organic anion uptake. (A and B) Time course of organic anion uptake by rOAT1 and rOAT3. S2 rOAT1 (A) and S2 rOAT3 (B) and S2 pcDNA3.1 were incubated in a solution containing 5 μM [14C]PAH and 50 nM [3H]ES at 37°C during the incubation time up to 15 min. (C and D) Inhibition experiments. S2 rOAT1 (C), S2 rOAT3 (D), and S2 pcDNA3.1 were incubated in a solution containing 5 μM [14C]PAH and 50 nM [3H]ES at 37°C for 2 min in the absence or presence of various concentrations of IS. The values are expressed as a percentage of organic anion uptake in S2 rOAT1, S2 rOAT3, or S2 pcDNA3.1 in the absence of IS. Each value represents the mean ± SEM of four determinations from one typical experiment. *P < 0.01 versus control.

Figure4
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 4. Kinetic analysis of the inhibitory effects of IS on rOAT1- and rOAT3-mediated organic anion uptake. S2 rOAT1 (A and B) and S2 rOAT3 (C and D) were incubated at 37°C for 2 min in a solution containing various concentrations of [14C]PAH and [3H]ES in the absence (•) or presence (▪, 250 μM;□), 1000 μM) of IS. Lineweaver-Burke plot analysis (A and C) and Eadie-Hofstee plot analysis (B and D) were performed. Each value represents the mean ± SEM of four determinations from one typical experiment.

HPLC Determination of IS Content in S2 rOAT1 and S2 rOAT3

To determine whether rOAT1 and rOAT3 mediate the uptake of IS, we measured the intracellular content of IS using HPLC. As shown in Figure 5, S2 rOAT1 (A) and S2 rOAT3 (B) showed a significantly higher intracellular IS content compared with that in S2 pcDNA 3.1 (n = 4; *P < 0.01 versus S2 pcDNA 3.1). In addition, we have examined the effects of organic anion transport inhibitors on IS uptake mediated by rOAT1 and rOAT3. Organic anion transport inhibitors used were probenecid and cilastatin (41). Probenecid and cilastatin dose-dependently inhibited the organic anion uptake by S2 rOAT1 and S2 rOAT3 at concentrations up to 2 mM (data not shown). As shown in Figures 5A and 5B, probenecid and cilastatin at 1 mM significantly inhibited IS uptake mediated by rOAT1 and rOAT3 (n = 4; #P < 0.05 versus S2 rOAT1 or S2 rOAT3; ##P < 0.01 versus S2 rOAT1 or S2 rOAT3). Both probenecid and cilastatin exhibited no significant inhibitory effects on IS uptake by S2 pcDNA 3.1 (data not shown).

Figure5
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 5. Intracellular IS content in S2 cells determined by HPLC. Confluent S2 rOAT1 (A), S2 rOAT3 (B), and S2 pcDNA 3.1 in six-well plates were incubated in a solution containing 100 μM IS in the absence or presence of 1 mM probenecid or 1 mM cilastatin at 37°C for 2, 5, 15, and 30 min. After washing the cells with a solution, the intracellular IS contents were determined using HPLC. Each value represents the mean ± SEM of three determinations from one typical experiment. *P < 0.01 versus S2 pcDNA3.1; #P < 0.05 versus S2 rOAT1 or S2 rOAT3; ##P < 0.01 versus S2 rOAT1 or S2 rOAT3.

Effects of IS on the Viability of S2 rOAT1 and S2 rOAT3 in the Absence or Presence of Probenecid

We determined whether accumulated IS within the cells induced toxicity in S2 rOAT1 and S2 rOAT3. For this purpose, we examined the effects of various concentrations of IS on the viability of S2 rOAT1, S2 rOAT3, and S2 pcDNA 3.1 using the MTT colorimetric assay. As shown in Figure 6, IS after 24-h culture significantly decreased the viability of S2 rOAT1 (A), but not that of S2 rOAT3 (B), compared with that of S2 pcDNA 3.1 (n = 4; *P < 0.05 and **P < 0.01 versus S2 pcDNA3.1, respectively). In contrast, the viability after 48 hr culture was significantly decreased in both S2 rOAT1 and S2 rOAT3 compared with that of S2 pcDNA3.1 (Figure 6, A and B; n = 4; **P < 0.01 versus S2 pcDNA3.1). To confirm the role of rOAT1 and rOAT3 in the IS-induced nephrotoxicity, we evaluated the effects of probenecid, an organic anion transport inhibitor (41), on the IS-induced decrease in the viability. As shown in Figure 6, 1 mM probenecid significantly reversed the decrease in the viability of S2 rOAT1 (A) and S2 rOAT3 (B) treated with IS (n = 4; #P < 0.05). Addition of 1 mM probenecid alone did not show any significant effects on the cell viability (data not shown).

Figure6
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 6. Effects of IS on the viability of S2 rOAT1, S2 rOAT3, and S2 pcDNA3.1 in the absence or presence of probenecid. S2 rOAT1 (A), S2 rOAT3 (B), and S2 pcDNA3.1 in 24-well plates were incubated in a solution containing 10, 25, or 50 μM IS in the absence or presence of 1 mM probenecid for 24 or 48 hr. Each value represents the mean ± SEM of four determinations from one typical experiment. *P < 0.05 and **P < 0.01 versus S2 pcDNA3.1; #P < 0.01 versus S2 rOAT1 or rOAT3.

Discussion

In the progression of CRF, tubulointerstitial damage develops even if the glomerulus is the primary site of injury, and the level of tubulointerstitial damage has been suggested to be a good indicator to predict prognosis (42,43). Progressive damage to the renal interstitium destroys extensive amounts of kidney tissue and results in considerable reduction of renal function. Although immunologic disorders may play a major role in the development of tubulointerstitial damage (44), we have previously proposed that the accumulation of uremic toxins in the tubular cells also plays an important role, especially in progressive CRF (15).

Both rOAT1 and rOAT3 mediate the basolateral uptake of various drugs and endogenous organic anions such as nonsteroidal antiinflammatory drugs, antitumor drugs, H2-receptor antagonists, prostaglandins, diuretics, angiotensin-converting enzyme inhibitors, and β-lactam antibiotics (18,21). Some characteristic differences exist between rOAT1 and rOAT3, such as substrate specificity, affinity, and localization. rOAT1 is localized at the basolateral side of the S2 segment of the proximal tubules (30); rOAT3 is found in the first, second, and third segments (S1, S2, and S3) of the proximal tubules (32). In addition, rOAT1, but not rOAT3, exhibits transport properties that are typical of an exchanger (18,21).

IS is a small and relatively hydrophobic organic anion (Figure 1) that possesses the typical chemical structure accepted by the OATs. IS administration to 5/6-NPX rats accelerated the progression of CRF as indicated by the increased serum concentrations of creatinine and BUN and the decreased creatinine clearance levels compared with those of 5/6-NPX rats (Table 1). The serum concentration of IS in IS-administered 5/6-NPX rats (mean, 156 approximately 226 μM) was comparable to those of hemodialysis patients (mean, 249 μM) (13). Immunohistochemical analyses revealed that rOAT1 and rOAT3 in control rats were localized to the basolateral membrane of renal tubules, whereas IS was weakly detected. In contrast, IS staining in 5/6-NPX rats was more marked in the renal tubules, where rOAT1 and rOAT3 were also detected. IS staining was more remarkable in 5/6-NPX rats treated with IS. On the basis of these results, we suggest that the increased serum IS concentration leads to the accumulation of IS within the renal tubules by the uptake of IS via rOAT1 and rOAT3 by the mechanisms confirmed by the in vitro experiment carried out in this study. The accumulated IS may subsequently accelerate the progression of tubulointerstitial damage. The rOAT3 protein was more broadly distributed than that of rOAT1, i.e., not only in the proximal tubules but also in the distal tubules. In addition, the Ki value of IS for rOAT3-mediated organic anion uptake was about twice of that for rOAT1. It is thus possible that rOAT3 plays a dominant role for the uptake of IS in CRF to cause nephrotoxicity. IS staining was colocalized with rOAT3 but not with rOAT1 (Figure 2). Considering the Ki values of rOAT1 and rOAT3 for IS, it is possible that the colocalization of rOAT3 with IS is a phenomenon that is seen only at high IS levels after rOAT1 becomes saturated and rOAT3 becomes the major contributor.

We also observed the changes in the levels of rOAT1 and rOAT3 proteins by immunohistochemistry and found that the expression of rOAT3 seems to be increased in 5/6-NPX rats compared with normal rats, whereas that of rOAT1 was increased slightly (Figure 2). This finding appears to reflect the previous observation that the secretory capacity for organic anion was increased per nephron basis when the nephron mass decreased (45). The changes of expressions of both rOAT1 and rOAT3 in CRF rats should also be quantified in the future investigation using Western and Northern blot analyses. Although the present study mainly focused on IS as an endogenous organic anion, a similar mechanism may operate for other anionic uremic toxins. In uremia, various anionic uremic toxins may accumulate in the proximal tubular cells, some of which may be as potentially nephrotoxic as IS.

Although the progressive nature of chronic renal disease has been extensively investigated in 5/6-NPX rats, the mechanisms responsible for the compensatory hypertrophy are still controversial (46–48). It has been suggested that the adaptations associated with the compensatory changes are maladaptive and result in eventual glomerulosclerosis of the initially normal remnant nephrons. In this study, both toxic effects of IS and progression of adaptive changes in the remnant nephrons may coexist in the nephrectomized model; it therefore seems difficult to distinguish the contributions of these two pathogenic mechanisms. We assume that the increased expression level of OAT3 is an adaptive change that takes place during the accumulation of serum organic acids such as IS, although its upregulation mechanism requires further in vitro investigation.

Regarding extrarenal distribution of OAT1 and OAT3, it has been demonstrated using Northern blot analyses or reverse transcription-PCR that OAT1 (18,49) and OAT3 (21) are expressed not only in the kidney but also in the brain. It is therefore important to investigate the OAT-mediated transport of such uremic toxins as IS across the blood-brain barrier and to clarify the mechanism of neurologic symptoms of uremic syndrome in CRF patients.

IS inhibited rOAT1- and rOAT3-mediated organic anion uptake, and those inhibitions were competitive. The Ki values were comparable with the serum concentration of IS in uremic rats, i.e., 55 approximately 226 μM (Table 1). These results suggest that IS interacts with rOAT1 and rOAT3 not only in vitro but also in vivo. It is important to note that approximately 90% of IS is bound to albumin in vivo; the interaction between IS and these transporters is therefore not perfectly consistent with the in vitro model. However, the observed high level of IS secretion into the urine in 5/6-NPX rats could not be explained by glomerular filtration only (Table 1). A further in vitro study is necessary to investigate the interaction between these transporters and IS in the presence of albumin.

The addition of IS at concentrations relevant to in vivo conditions resulted in a significant decrease in the viability of S2 rOAT1 and S2 rOAT3, whereas no significant change was observed in that of S2 pcDNA 3.1. In addition, this decrease in viability was inhibited by the simultaneous administration of probenecid. The concentration of probenecid used in the current study (1 mM) was shown in previous studies to inhibit cephaloridine-induced and ochratoxin A-induced nephrotoxicity in S3 cells stably expressing rOAT1 (38,50). Furthermore, as described above, HPLC analyses revealed that rOAT1 and rOAT3 mediate the accumulation of IS, which was inhibited by probenecid and cilastatin (Figure 5). On the basis of these results, we suggest that IS is taken up via rOAT1 and rOAT3, accumulates within the cells, and induces cytotoxicity. The extent of viability in S2 rOAT1 and S2 rOAT3 treated with IS and probenecid for 48 h was approximately 40% more than that treated with IS alone. On the other hand, the amount of IS in S2 rOAT1 and S2 rOAT3 treated with IS and probenecid for 30 min was approximately 80% less than that treated with IS alone. This apparent discrepancy may be due to the difference in experimental setting, i.e., 30-min incubation in D-PBS for uptake experiments and 48-h culture in RITC containing FBS and growth factors for viability experiments. In addition, although viability was significantly decreased in S2 rOAT1 but not in S2 rOAT3 for the 24-h culture, the extents of viability for the corresponding 48-h cultures between S2 rOAT1 and S2 rOAT3 were similar. This phenomenon was also observed in S2 rOAT3 treated with cephaloridine (38) and in S2 hOAT1 and S2 hOAT3 treated with ochratoxin A (unpublished observation), although the reason for this remains unclear. The intracellular mechanisms of nephrotoxicity induced by IS accumulation should be further elucidated.

In conclusion, we clarify that IS is one of the important uremic toxins that are transported by OAT1 and OAT3. Thus, accumulated IS may cause cellular functions to decrease, although its intracellular mechanisms await further investigation.

Acknowledgments

We thank Dr. Hideyuki Yamato and Dr. Junji Kakuchi (Kureha Chemical Industry Co., Ltd., Biomedical Research Laboratories, Tokyo, Japan) for their collaboration. This work was supported in part by grants from the Japanese Ministry of Education, Science, Sports and Culture, Grants-in-Aids for Scientific Research and High-Tech Research Center, the Science Research Promotion Fund of Japan Private School Promotion Foundation.

  • © 2002 American Society of Nephrology

References

  1. ↵
    Klahr S, Buerkert J, Purkerson ML: Role of dietary factors in the progression of chronic renal disease. Kidney Int 24: 579–587, 1983
    OpenUrlCrossRefPubMed
  2. ↵
    Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 647–655, 1983
    OpenUrlCrossRefPubMed
  3. ↵
    Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G: The effect of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330: 877–884, 1994
    OpenUrlCrossRefPubMed
  4. ↵
    Modification of diet in renal disease study group: Effects of dietary protein restriction on the progression of moderate renal disease in the modification of diet in renal disease study. J Am Soc Nephrol 7: 2616–2626, 1996
    OpenUrlAbstract
  5. ↵
    Correa-Rotter ME, Hostetter TH, Rosenberg ME: Effect of dietary protein on renin and angiotensinogen gene expression after renal ablation. Am J Physiol 262: F631–F638, 1992
    OpenUrlPubMed
  6. ↵
    Rosenberg ME, Chmielewski D, Hostetter TH: Effect of dietary protein on rat rennin and angiotensinogen expression. J Clin Invest 85: 1144–1149, 1990
  7. ↵
    Eddy AA: Protein restriction reduces transforming growth factor-beta and interstitial fibrosis in nephritic syndrome. Am J Physiol 266: F884–F893, 1994
    OpenUrlPubMed
  8. ↵
    Daniels BS, Hostetter TH: Effects of dietary protein intake on vasoactive hormones. Am J Physiol 258: F1095–F1100, 1990
    OpenUrl
  9. ↵
    Follenius M, Branderberger G, Hetter B: Diurnal cortisol peaks and their relationship to meals. J Clin Endocrinol Metab 55: 757–761, 1982
    OpenUrlCrossRefPubMed
  10. ↵
    Slag MF, Ahmed M, Gannon MC, Nuttal FQ: Meal stimulation of cortisol secretion: A protein induced effect. Metabolism 30: 1104–1108, 1981
    OpenUrlCrossRefPubMed
  11. ↵
    Niwa T, Nomura T, Sugiyama S, Miyazaki T, Tsukushi S, Tsutsui S: The protein metabolite hypothesis, a model for the progression of renal failure: An oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Kidney Int 52 [suppl 62]: S23–S28, 1997
    OpenUrl
  12. ↵
    Niwa T, Ise M: Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. J Lab Clin Med 124: 96–104, 1994
    OpenUrlPubMed
  13. ↵
    Niwa T, Ise M, Miyazaki T: Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate. Am J Nephrol 14: 207–212, 1994
    OpenUrlCrossRefPubMed
  14. ↵
    Niwa T, Tsukushi S, Ise M, Miyazaki T, Tsubakihara Y, Owada A, Shiigai T: Indoxyl sulfate and progression of renal failure: Effects of low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Miner Electrolyte Metab 23: 179–184, 1997
    OpenUrlPubMed
  15. ↵
    Miyazaki T, Aoyama I, Ise M, Seo H, Niwa T: An oral adsorbent reduces overload of indoxyl sulfate and gene TGF-beta1 in uremic rat kidneys. Nephrol Dial Transplant 20: 232–241, 2000
    OpenUrl
  16. ↵
    Moller JV, Sheikh MI: Renal organic anion transport system: Pharmacological, physiological, and biochemical aspects. Pharmacol Rev 34: 315–358, 1983
    OpenUrlPubMed
  17. ↵
    Pritchard JB, Miller DS: Mechanisms mediating renal secretion of organic anions and cations. Physiol Rev 73: 765–796, 1993
    OpenUrlPubMed
  18. ↵
    Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H: Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem 272: 18526–18529, 1997
    OpenUrlAbstract/FREE Full Text
  19. ↵
    Hosoyamada M, Sekine T, Kanai Y, Endou H: Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am J Physiol 45: F 122–F128, 1999
    OpenUrl
  20. ↵
    Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima N, Kanai Y, Endou H: Identification of organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 429: 179–182, 1998
    OpenUrlCrossRefPubMed
  21. ↵
    Kusuhara H, Sekine T, Utsunomiya-Tate N, Tsuda M, Kojima R, Cha SH, Sugiyama Y, Kanai Y, Endou H: Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J Biol Chem 274: 13675–13680, 1999
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Cha SH, Sekine T, Fukushima JI, Kanai Y, Kobayashi Y, Goya T, Endou H: Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol 59: 1277–86, 2001
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Cha SH, Sekine T, Kusuhara H, Yu E, Kim JY, Kim DK, Sugiyama Y, Kanai Y, Endou H: Molecular cloning and characterization of multispecific organic anion transporter 4 expressed in the placenta. J Biol Chem 275: 4507–4512, 2000
    OpenUrlAbstract/FREE Full Text
  24. ↵
    Jacquemin E, Hagenbuch B, Stieger B, Wolkoff AW, Meier PJ: Expression cloning of a rat liver Na+-independent organic anion transporter. Proc Natl Acad Sci USA 91: 133–137, 1994
    OpenUrlAbstract/FREE Full Text
  25. ↵
    Saito H, Masuda S, Inui K: Cloning and functional characterization of a novel rat organic anion transporter mediating basolateral uptake of methotrexate in the kidney. J Biol Chem 271: 20719–20275, 1996
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Masuda S, Ibaramoto K, Takeuchi A, Saito H, Hashimoto Y, Inui KI: Cloning and functional characterization of a new multispecific organic anion transporter. OAT-K2, in rat kidney. Mol Pharmacol 55: 743–753, 1999
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Leier I, Hummel-Eisenbeiss J, Cjhi Y, Keppler D: ATP-dependent para-aminohippurate transport by apical multidrug resistance protein MRP2. Kidney Int 57: 1636–1642, 2000
    OpenUrlCrossRefPubMed
  28. ↵
    Van Aubel RA, Peters JG, Masereeuw R, Van Os CH, Russel FG: Multidrug resistance protein mrp2 mediates ATP-dependent transport of classic renal organic anion p-aminohippurate. Am J Physiol Renal Physiol 279: F713–F717, 2000
    OpenUrlPubMed
  29. ↵
    Uchino H, Tamai I, Yamashita K, Minemoto Y, Sai Y, Yabuuchi H, Miyamoto KI, Takeda E, Tsuji A: p-Aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1. Biochem Biophys Res Commun 270: 254–259, 2000
    OpenUrlCrossRefPubMed
  30. ↵
    Tojo A, Sekine T, Nakajima N, Hosoyamada M, Kanai Y, Kimura K, Endou H: Immunohistchemical localization of multispecific renal organic anion transporter 1 in rat kidney. J Am Soc Nephrol 10: 464–471, 1999
    OpenUrlAbstract/FREE Full Text
  31. Hasegawa M, Kusuhara H, Sugiyama D, Ito K, Ueda S, Endou H, Sugiyama Y: Functional involvement of rat organic anion transporter 3 (rOat3; Slc22a8) in the renal uptake of organic anions. J Pharmacol Exp Ther 300: 746–753, 2002
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Kojima R, Sekine T, Kawachi M, Cha SH, Suzuki Y, Endou H: Immunolocalization of multispecific organic anion transporters, OAT1, OAT2, and OAT3, in rat kidney. J Am Soc Nephrol 13: 848–857, 2002
    OpenUrlAbstract/FREE Full Text
  33. ↵
    Morrison AB, Howard RM: The functional capacity of hypertrophied nephrons. Effect of partial nephrectomy on the clearance of inulin and PAH in the rat. J Exp Med 123: 5: 829–844, 1966
    OpenUrlAbstract
  34. ↵
    Shimamura T, Morrison AB: A progressive glomerulosclerosis occurring in partial five-sixths nephrectomized rats. Am J Pathol 79: 95–106, 1975
    OpenUrlPubMed
  35. ↵
    Hosoyamada M, Obinata M, Suzuki M, Endou H: Cisplatin-induced toxicity in immortalized renal cell lines established from transgenic mice harboring temperature sensitive SV40 large T-antigen gene. Arch Toxicol 70: 284–292, 1996
    OpenUrlCrossRefPubMed
  36. ↵
    Takeda M, Tojo A, Sekine T, Hosoyamada M, Kanai Y, Endou H: Role of organic anion transporter 1 (OAT1) in cephaloridine (CER)-induced nephrotoxicity. Kidney Int 56: 2128–2136, 1999
    OpenUrlCrossRefPubMed
  37. ↵
    Takeda M, Sekine T, Endou H: Regulation by protein kinase C of organic anion transport driven by rat organic anion transporter 3. Life Sci 67: 1087–1093, 2000
    OpenUrlCrossRefPubMed
  38. ↵
    Jung KY, Takeda: M, Shimoda M, Narikawa S, Tojo A, Kim DK, Chairoungdua A, Choi BK, Sekine T, Endou H: Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: In comparison with rOAT1. Life Sci 70: 1861–1874, 2002
    OpenUrlCrossRefPubMed
  39. ↵
    Apiwattanakul N, Sekine T, Chairoungdua A, Kanai Y, Nakajima N, Sophasan S, Endou H: Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in xenopus laevis oocytes. Mol Pharmacol 55: 847–854, 1999
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Niwa T, Takeda N, Tatematsu A, Maeda K: Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. Clin Chem 34: 2264–2267, 1988
    OpenUrlAbstract/FREE Full Text
  41. ↵
    Takeda M, Narikawa S, Hosoyamada M, Cha SH, Sekine T, Endou H: Characterization of organic anion transport inhibitor using cells stably expressing human organic anion transporters. Eur J Pharmacol 419: 113–120, 2001
    OpenUrlCrossRefPubMed
  42. ↵
    Bohle A, Mackensen-Haen S, von Gise H: Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. Am J Nephrol 7: 421–433, 1987
    OpenUrlCrossRefPubMed
  43. ↵
    Risdon RA, Sloper JC, deWardener HE: Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet 2: 363–366, 1968
    OpenUrlCrossRefPubMed
  44. ↵
    Kelly CJ, Neilson EG: Tubulointerstitial diseases.In: The Kidney, 6th Ed., edited by Brenner BM, Philadelphia, WB Saunders, 2000,pp 1509–1536
  45. ↵
    Sica DA, Schoolwerth AC: Renal handling of organic anions and cations: Excretion of uric acid.In: The Kidney,Vol. 1, 6th Ed., edited by Brenner BM, Philadelphia W B. Saunders Company, 2000,pp 680–700
  46. ↵
    Purkerson ML, Hofsten PE, Klahr S: Pathogenesis of the glomerulopathy associated with renal infarction in rats. Kidney Int 9: 407–417, 1976
    OpenUrlPubMed
  47. Brenner BM: Nephron adaptation to renal injury or ablation. Am J Physiol 249: F324–F337, 1985
    OpenUrlPubMed
  48. ↵
    Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 318: 1657–1666, 1988
    OpenUrlCrossRefPubMed
  49. ↵
    Cihlar T, Lin DC, Pritchard JB, Fuller MD, Mendel DB, Sweet DH: The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol Pharmacol 56: 570–580, 1999
    OpenUrlAbstract/FREE Full Text
  50. ↵
    Tsuda M, Sekine T, Takeda M, Cha SH, Kimura M, Kanai Y, Endou H: Transport of ochratoxin A by renal multispecific organic anion transporter 1. J Pharmacol Exp Ther 289: 1301–1305, 1999
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Journal of the American Society of Nephrology: 13 (7)
Journal of the American Society of Nephrology
Vol. 13, Issue 7
1 Jul 2002
  • Table of Contents
  • Index by author
View Selected Citations (0)
Print
Download PDF
Sign up for Alerts
Email Article
Thank you for your help in sharing the high-quality science in JASN.
Enter multiple addresses on separate lines or separate them with commas.
Role of Organic Anion Transporters in the Tubular Transport of Indoxyl Sulfate and the Induction of its Nephrotoxicity
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Role of Organic Anion Transporters in the Tubular Transport of Indoxyl Sulfate and the Induction of its Nephrotoxicity
Atsushi Enomoto, Michio Takeda, Akihiro Tojo, Takashi Sekine, Seok Ho Cha, Suparat Khamdang, Fumio Takayama, Isao Aoyama, Sakurako Nakamura, Hitoshi Endou, Toshimitsu Niwa
JASN Jul 2002, 13 (7) 1711-1720; DOI: 10.1097/01.ASN.0000022017.96399.B2

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Role of Organic Anion Transporters in the Tubular Transport of Indoxyl Sulfate and the Induction of its Nephrotoxicity
Atsushi Enomoto, Michio Takeda, Akihiro Tojo, Takashi Sekine, Seok Ho Cha, Suparat Khamdang, Fumio Takayama, Isao Aoyama, Sakurako Nakamura, Hitoshi Endou, Toshimitsu Niwa
JASN Jul 2002, 13 (7) 1711-1720; DOI: 10.1097/01.ASN.0000022017.96399.B2
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Data Supps
  • Info & Metrics
  • View PDF

More in this TOC Section

  • Increased Renal Responsiveness to Vasopressin and Enhanced V2 Receptor Signaling in RGS2−/− Mice
  • Impairment of Sodium Balance in Mice Deficient in Renal Principal Cell Mineralocorticoid Receptor
  • Acute Regulation of the Epithelial Na+ Channel by Phosphatidylinositide 3-OH Kinase Signaling in Native Collecting Duct Principal Cells
Show more Cell and Transport Physiology

Cited By...

  • Probiotic Lactobacillus paracasei HII01 protects rats against obese-insulin resistance-induced kidney injury and impaired renal organic anion transporter 3 function
  • Abundance of Drug Transporters in the Human Kidney Cortex as Quantified by Quantitative Targeted Proteomics
  • Protein-bound toxins: has the Cinderella of uraemic toxins turned into a princess?
  • Serum Concentrations of p-Cresyl Sulfate and Indoxyl Sulfate, but Not Inflammatory Markers, Increase in Incident Peritoneal Dialysis Patients in Parallel with Loss of Residual Renal Function
  • Cardiorenal Syndrome: The Emerging Role of Protein-Bound Uremic Toxins
  • Interrelationship Between Cardiac Hypertrophy, Heart Failure, and Chronic Kidney Disease: Endoplasmic Reticulum Stress As a Mediator of Pathogenesis
  • Indoxyl Sulfate-Induced Endothelial Dysfunction in Patients with Chronic Kidney Disease via an Induction of Oxidative Stress
  • Indoxyl Sulfate Induces Leukocyte-Endothelial Interactions through Up-regulation of E-selectin
  • Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients
  • Dialysis at a Crossroads: Reverse Engineering Renal Replacement Therapy
  • Uptake of Chemically Reactive, DNA-Damaging Sulfuric Acid Esters into Renal Cells by Human Organic Anion Transporters
  • The Molecular Pharmacology of Organic Anion Transporters: from DNA to FDA?
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Annual Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • Editorial Fellowship Program
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • JASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About JASN
  • JASN Email Alerts
  • JASN Key Impact Information
  • JASN Podcasts
  • JASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2021 American Society of Nephrology

Print ISSN - 1046-6673 Online ISSN - 1533-3450

Powered by HighWire